RITA NTOSI: Open Payments
NPI 1700153210 · GREENBELT, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$738 in 8 payments from 5 companies in 2025. Trend: 2023 $102 · 2024 $665 · 2025 $738
Food & beverage: $738
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 3 | $253 |
| Neurocrine BioSciences, Inc. | 2 | $231 |
| Merck Sharp & Dohme LLC | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $105 |
| Novo Nordisk Inc | 1 | $24 |
Products named: REXULTI, INGREZZA, CAPVAXIVE, COBENFY.
Industry payments across MD — which companies pay providers there.
